Literature DB >> 16344587

Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication.

H Ye, L Gong, H Liu, A Ruskone-Fourmestraux, D de Jong, S Pileri, C Thiede, A Lavergne, H Boot, G Caletti, T Wündisch, T Molina, B G Taal, S Elena, A Neubauer, K A Maclennan, R Siebert, E D Remstein, A Dogan, M-Q Du.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16344587      PMCID： PMC1856390          DOI： 10.1136/gut.2005.081117

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

Review 1.  MALT lymphoma: from morphology to molecules.

Authors:  Peter G Isaacson; Ming-Qing Du
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

2.  Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group.

Authors:  M Sackmann; A Morgner; B Rudolph; A Neubauer; C Thiede; H Schulz; W Kraemer; G Boersch; P Rohde; E Seifert; M Stolte; E Bayerdoerffer
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

3.  Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori.

Authors:  S Nakamura; T Matsumoto; H Suekane; M Takeshita; K Hizawa; M Kawasaki; T Yao; M Tsuneyoshi; M Iida; M Fujishima
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma.

Authors:  Hongtao Ye; Hongxiang Liu; Ayoma Attygalle; Andrew C Wotherspoon; Andrew G Nicholson; Frederic Charlotte; Veronique Leblond; Paul Speight; John Goodlad; Anne Lavergne-Slove; Jose Ignacio Martin-Subero; Reiner Siebert; Ahmet Dogan; Peter G Isaacson; Ming-Qing Du
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

5.  T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.

Authors:  Hongxiang Liu; Hongtao Ye; Agnes Ruskone-Fourmestraux; Daphne De Jong; Stefano Pileri; Christian Thiede; Anne Lavergne; Henk Boot; Giancarlo Caletti; Thomas Wündisch; Thierry Molina; Babs G Taal; Sabattini Elena; Togliani Thomas; Pier Luigi Zinzani; Andreas Neubauer; Manfred Stolte; Rifat A Hamoudi; Ahmet Dogan; Peter G Isaacson; Ming-Qing Du
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

6.  MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.

Authors:  Hongtao Ye; Liping Gong; Hongxiang Liu; Rifat A Hamoudi; Sima Shirali; Liza Ho; Andreas Chott; Berthold Streubel; Reiner Siebert; Stefan Gesk; Jose I Martin-Subero; John A Radford; Sankar Banerjee; Andrew G Nicholson; Renzo Ranaldi; Ellen D Remstein; Zifen Gao; Jie Zheng; Peter G Isaacson; Ahmet Dogan; Ming-Qing Du
Journal:  J Pathol       Date:  2005-02       Impact factor: 7.996

7.  Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.

Authors:  A Ruskoné-Fourmestraux; A Lavergne; P H Aegerter; F Megraud; L Palazzo; A de Mascarel; T Molina; J L Rambaud
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

8.  Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.

Authors:  T G Willis; D M Jadayel; M Q Du; H Peng; A R Perry; M Abdul-Rauf; H Price; L Karran; O Majekodunmi; I Wlodarska; L Pan; T Crook; R Hamoudi; P G Isaacson; M J Dyer
Journal:  Cell       Date:  1999-01-08       Impact factor: 41.582

9.  Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).

Authors:  Q Zhang; R Siebert; M Yan; B Hinzmann; X Cui; L Xue; K M Rakestraw; C W Naeve; G Beckmann; D D Weisenburger; W G Sanger; H Nowotny; M Vesely; E Callet-Bauchu; G Salles; V M Dixit; A Rosenthal; B Schlegelberger; S W Morris
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330
  9 in total
  9 in total

Review 1.  Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management.

Authors:  M-Q Du; J C Atherton
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

2.  Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations.

Authors:  Sumit Bhattacharyya; Alip Borthakur; Pradeep K Dudeja; Joanne K Tobacman
Journal:  Exp Cell Res       Date:  2010-05-11       Impact factor: 3.905

Review 3.  Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.

Authors:  Chris M Bacon; Ming-Qing Du; Ahmet Dogan
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

4.  Pulmonary mucosa-associated lymphoid tissue lymphoma with strong nuclear B-cell CLL/lymphoma 10 (BCL10) expression and novel translocation t(1;2)(p22;p12)/immunoglobulin kappa chain-BCL10.

Authors:  Shih-Sung Chuang; Hongxiang Liu; Jose I Martín-Subero; Reiner Siebert; Wen-Tsung Huang; Hongtao Ye
Journal:  J Clin Pathol       Date:  2006-11-10       Impact factor: 3.411

5.  Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma.

Authors:  Zhaoyang Li; Hongsheng Wang; Liquan Xue; Dong-Mi Shin; Derry Roopenian; Wu Xu; Chen-Feng Qi; Mark Y Sangster; Carlos J Orihuela; Elaine Tuomanen; Jerold E Rehg; Xiaoli Cui; Quangeng Zhang; Herbert C Morse; Stephan W Morris
Journal:  Blood       Date:  2009-08-20       Impact factor: 22.113

Review 6.  B-cell receptor signaling as a driver of lymphoma development and evolution.

Authors:  Carsten U Niemann; Adrian Wiestner
Journal:  Semin Cancer Biol       Date:  2013-09-20       Impact factor: 15.707

7.  Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significance.

Authors:  S-H Kuo; L-T Chen; C-W Lin; M-S Wu; P-N Hsu; H-J Tsai; C-Y Chu; Y-S Tzeng; H-P Wang; K-H Yeh; A-L Cheng
Journal:  Blood Cancer J       Date:  2013-07-12       Impact factor: 11.037

8.  First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Sung-Hsin Kuo; Kun-Huei Yeh; Ming-Shiang Wu; Chung-Wu Lin; Ming-Feng Wei; Jyh-Ming Liou; Hsiu-Po Wang; Li-Tzong Chen; Ann-Lii Cheng
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

Review 9.  Recent Advances in the Genetic of MALT Lymphomas.

Authors:  Juan José Rodríguez-Sevilla; Antonio Salar
Journal:  Cancers (Basel)       Date:  2021-12-30       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.